Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presum...
Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis”
About this item
Full title
Author / Creator
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Another limitation is the lack of data on the proportion of dogs treated as outpatients (presenting with milder clinical signs and requiring less care) compared with those requiring intensive care. Because IV fluid administration is the cornerstone of AP treatment, detailed information on the number of dogs receiving fluids (including volume and du...
Alternative Titles
Full title
Letter regarding “Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis”
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6bae9d9ad35645258e859d61852422a7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6bae9d9ad35645258e859d61852422a7
Other Identifiers
ISSN
0891-6640
E-ISSN
1939-1676
DOI
10.1111/jvim.17025